Fidelity Investments’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.97M | Buy |
625,446
+375,541
| +150% | +$4.18M | ﹤0.01% | 2058 |
|
|
2025
Q1 | $3.07M | Buy |
249,905
+234
| +0.1% | +$2.88K | ﹤0.01% | 2318 |
|
|
2024
Q4 | $2.79M | Buy |
249,671
+261
| +0.1% | +$2.92K | ﹤0.01% | 2340 |
|
|
2024
Q3 | $1.74M | Buy |
249,410
+16
| +0% | +$112 | ﹤0.01% | 2437 |
|
|
2024
Q2 | $1.89M | Sell |
249,394
-53,409
| -18% | -$404K | ﹤0.01% | 2361 |
|
|
2024
Q1 | $4M | Sell |
302,803
-165,278
| -35% | -$2.18M | ﹤0.01% | 2134 |
|
|
2023
Q4 | $4.83M | Sell |
468,081
-238,164
| -34% | -$2.46M | ﹤0.01% | 2076 |
|
|
2023
Q3 | $6.87M | Sell |
706,245
-517,418
| -42% | -$5.03M | ﹤0.01% | 1944 |
|
|
2023
Q2 | $5.49M | Sell |
1,223,663
-269,268
| -18% | -$1.21M | ﹤0.01% | 2039 |
|
|
2023
Q1 | $6.93M | Buy |
1,492,931
+43,005
| +3% | +$200K | ﹤0.01% | 2001 |
|
|
2022
Q4 | $2.16M | Hold |
1,449,926
| – | – | ﹤0.01% | 2355 |
|
|
2022
Q3 | $5.44M | Buy |
1,449,926
+30,975
| +2% | +$116K | ﹤0.01% | 2141 |
|
|
2022
Q2 | $7.02M | Buy |
1,418,951
+11,645
| +0.8% | +$57.6K | ﹤0.01% | 2120 |
|
|
2022
Q1 | $11.6M | Buy |
1,407,306
+341,269
| +32% | +$2.8M | ﹤0.01% | 2053 |
|
|
2021
Q4 | $10.7M | Buy |
1,066,037
+652
| +0.1% | +$6.57K | ﹤0.01% | 2090 |
|
|
2021
Q3 | $16.9M | Buy |
1,065,385
+5,326
| +0.5% | +$84.4K | ﹤0.01% | 1918 |
|
|
2021
Q2 | $25.2M | Buy |
+1,060,059
| New | +$25.2M | ﹤0.01% | 1740 |
|